[go: up one dir, main page]

WO2014143994A3 - Methods and compositions for evaluating genetic markers - Google Patents

Methods and compositions for evaluating genetic markers Download PDF

Info

Publication number
WO2014143994A3
WO2014143994A3 PCT/US2014/028212 US2014028212W WO2014143994A3 WO 2014143994 A3 WO2014143994 A3 WO 2014143994A3 US 2014028212 W US2014028212 W US 2014028212W WO 2014143994 A3 WO2014143994 A3 WO 2014143994A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
genetic markers
evaluating genetic
genetic loci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2014/028212
Other languages
French (fr)
Other versions
WO2014143994A2 (en
Inventor
Gregory Porreca
Mark UMBARGER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Good Start Genetics Inc
Original Assignee
Good Start Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/934,093 external-priority patent/US12129514B2/en
Application filed by Good Start Genetics Inc filed Critical Good Start Genetics Inc
Priority to CA2907177A priority Critical patent/CA2907177A1/en
Priority to EP14762322.7A priority patent/EP2971114A4/en
Publication of WO2014143994A2 publication Critical patent/WO2014143994A2/en
Publication of WO2014143994A3 publication Critical patent/WO2014143994A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Aspects of the invention relates to methods and compositions that are useful to reduce bias and increase the reproducibility of multiplex analysis of genetic loci. In some configurations, predetermined preparative steps and/or nucleic acid sequence analysis techniques are used in multiplex analyses for a plurality of genetic loci in a plurality of samples.
PCT/US2014/028212 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers Ceased WO2014143994A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2907177A CA2907177A1 (en) 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers
EP14762322.7A EP2971114A4 (en) 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361789164P 2013-03-15 2013-03-15
US61/789,164 2013-03-15
US13/934,093 US12129514B2 (en) 2009-04-30 2013-07-02 Methods and compositions for evaluating genetic markers
US13/934,093 2013-07-02

Publications (2)

Publication Number Publication Date
WO2014143994A2 WO2014143994A2 (en) 2014-09-18
WO2014143994A3 true WO2014143994A3 (en) 2015-02-19

Family

ID=51538293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/028212 Ceased WO2014143994A2 (en) 2013-03-15 2014-03-14 Methods and compositions for evaluating genetic markers

Country Status (3)

Country Link
EP (1) EP2971114A4 (en)
CA (1) CA2907177A1 (en)
WO (1) WO2014143994A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3055338B1 (en) * 2016-09-01 2020-05-29 Centre National De La Recherche Scientifique METHOD FOR IN VITRO DETECTION AND IDENTIFICATION OF ONE OR MORE MICROORGANISMS INVOLVED IN THE DEGRADATION, MODIFICATION OR SEQUENCING PROCESS OF ONE OR MORE CONTAMINANTS PRESENT IN A BIOLOGICAL SAMPLE
CN112029841B (en) * 2019-06-03 2024-02-09 香港中文大学 Method for quantifying telomere length and genomic motifs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070162983A1 (en) * 2003-11-19 2007-07-12 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
WO2010126614A2 (en) * 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US20120165202A1 (en) * 2009-04-30 2012-06-28 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2917881A4 (en) * 2012-11-07 2016-07-20 Good Start Genetics Inc Validation of genetic tests

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070162983A1 (en) * 2003-11-19 2007-07-12 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
WO2010126614A2 (en) * 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US20120165202A1 (en) * 2009-04-30 2012-06-28 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP2971114A4 *
THIYAGARAJAN, S ET AL., PATHOGENMIPER: A TOOL FOR THE DESIGN OF MOLECULAR INVERSION PROBES TO DETECT MULTIPLE PATHOGENS., 14 November 2006 (2006-11-14), pages PAGE 2 , PAGE 3, XP021021640 *

Also Published As

Publication number Publication date
EP2971114A2 (en) 2016-01-20
EP2971114A4 (en) 2016-11-23
CA2907177A1 (en) 2014-09-18
WO2014143994A2 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
WO2010126614A3 (en) Methods and compositions for evaluating genetic markers
HK1217971A1 (en) Methods, compositions, and kits for nucleic acid analysis
DK3901281T3 (en) SPATIALLY SEPARATE, MULTIPLEX NUCLEIC ACID ANALYSIS OF BIOLOGICAL SAMPLES
SG10201912283RA (en) Nucleic acid sequence analysis from single cells
PT3882357T (en) Methods and compositions for nucleic acid analysis
WO2016130704A3 (en) Methods and compositions for analyzing cellular components
WO2014145820A3 (en) Multiple tagging of long dna fragments
DK3565905T4 (en) NUCLEIC ACID SEQUENCEING USING AFFINITY REAGENTS
EP3169793A4 (en) Isothermal methods for amplifying nucleic acid samples
WO2014144822A3 (en) Methods and compositions for tagging and analyzing samples
DK3452591T3 (en) MACROMOLECULAR ANALYSIS USING NUCLEIC ACID CODING
WO2015195949A3 (en) Methods, compositions, and devices for rapid analysis of biological markers
WO2015200893A3 (en) Methods of analyzing nucleic acids from individual cells or cell populations
WO2017044993A3 (en) Nucleic acid analysis by joining barcoded polynucleotide probes
HK1222466A1 (en) Analysis of genetic variants
DK3152316T3 (en) Sample preparation for nucleic acid amplification
HK1256342A1 (en) Purification of nucleic acid from environmental or biological samples
MX376755B (en) Detection of target nucleic acids using hybridization
DK3320111T3 (en) Sample preparation for nucleic acid amplification
WO2014210199A3 (en) Methods of performing polymerase chain reaction and related uses thereof
WO2014008426A3 (en) Diagnosis of systemic lupus erythematosus
GB201506669D0 (en) Nucleic acid sample enrichment
SA517381859B1 (en) Characterization of Crude Oil by Ultraviolet Visible Spectroscopy
WO2014152091A3 (en) Methods of genome sequencing and epigenetic analysis
WO2014143994A3 (en) Methods and compositions for evaluating genetic markers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14762322

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2907177

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2014762322

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014762322

Country of ref document: EP